Health Condition 1: L408- Other psoriasis
Conditions
Interventions
None listed
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Pateints of every age and both genders Patients ready to participate in the trial Patients with presumed clinical diagnosis of acquired palmoplantar keratoderma
Exclusion criteria
Exclusion criteria: Patients with prior steroid or keratolytic therapy Patients not willing for biopsy Patients with coexistent systemic comorbidities Patients with hereditary palmoplantar keratodermas
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| By providing a better knowledge of dermoscopic features in acquired PPKs, the study will facilitate a quicker, efficient and non-invasive diagnosis of acquired PPKs. It will also help in taking more targeted therapeutic steps in management of palmoplantar psoriasis, leading to overall reduction in treatment time and increasing response rates. It will help explore the role of dermoscopy in follow-up of acquired PPKs.Timepoint: 1.5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| Evolution of dermoscopic features of palmoplantar psoriasis after 1 month of standard treatmentTimepoint: 1.5 years | — |
Countries
India
Contacts
Public ContactArshiya Khan
Jawaharlal Nehru Medical Collge, DMIHER, Wardha
Outcome results
None listed